[Small-diameter portosystemic shunts: indications and limitations]. / Derivaciones portosistémicas de bajo diámetro. Indicaciones y limitaciones.

Low diameter porto-systemic shunts for the treatment of portal hypertension bleeding have emerged as a consequence of the technical development of vascular grafts (PTFE) that allow the use of a narrow lumen. The experience with this kind of operation at the Instituto Nacional de la Nutrición Salvador Zubirán, Mexico City during a 6-year period is reported. There were twenty-seven patients with good liver function (Child-Pugh A-B) were operated or electively, average Age 47.5 years (range 17-71), twenty three patients with liver cirrhosis, one with portal fibrosis and three with idiopathic portal hypertension. Operative mortality: 4%. Rebleeding: 14%. Postoperative encephalopathy was observed in 14 of 27, three of them being grade III-IV (11%). In the remaining 11 cases, it was mild and easily controlled. Postoperative angiography showed shunt patency in 81% of the cases; in 33% of the cases, portal vein diameter reduction was shown, as well as two cases with portal vein thrombosis. In 77% of the cases, adequate postoperative quality of life was observed. Survival (Kaplan-Meier): 86% at 12 months and 56% at 60 months. These kinds of shunts are a good alternate choice for patients considered for surgery, in which other portal blood flow preserving procedures (selective shunts, devascularization with transection) are not feasible.

Selective shunts for portal hypertension: current role of a 21-year experience.

The results of treatment of hemorrhagic portal hypertension with selective shunts over a 21-year period in a selected patient population are reported. Patients selected for surgical treatment had good cardiopulmonary and renal function, and most also had adequate liver function (141 Child-Pugh class A, 59 class B). Among 734 patients treated surgically for bleeding portal hypertension, 221 had selective shunts (168 distal splenorenal and 53 splenocaval shunts). Global operative mortality (in the 21-year period) was 14% and 12% for Child-Pugh A patients. Operative mortality in Child-Pugh A patients in the last 5 years was only 5%. The rate of rebleeding was 6%, rate of incapacitating encephalopathy was 5%, and rate of survival was 65% at 15 years (last 5 years: 88% at 1 year and 85% at 5 years). Good quality of life was demonstrated in 80% of surviving patients. Shunt patency was 94%. Postoperative portal blood flow changes occurred in 23% of cases (8% diameter reduction, 14% thrombosis). Compared with other forms of therapy (pharmacotherapy, sclerotherapy, and transjugular intrahepatic shunting), only liver transplantation offers similar results for these patients. In countries in which liver transplantation is not routinely performed, shunting with selective shunts is the treatment of choice for patients with good liver function.

Distal splenorenal shunt versus 10-mm low-diameter mesocaval shunt for variceal hemorrhage.

BACKGROUND: Portal hypertension surgery remains a good therapeutic choice for well selected patients with variceal bleeding. The distal splenorenal shunt (DSRS) has shown good long-term results and low-diameter shunts have emerged as an alternate choice. METHODS: A prospective, controlled and not randomized study was designed to compare the DSRS (23 patients) and the low-diameter 10 mm ring reinforced PTFE mesocaval shunt (LDMCS) (22 patients) in low-risk electively operated patients (Child-Pugh A-B). The operation was selected according to the anatomical status of the veins. RESULTS: Both groups were comparable. No differences were observed regarding rebleeding, operative mortality and survival. Significative differences were observed regarding encephalopathy and shunt thrombosis (higher in the LDMCS). Postoperative angiography showed better maintenance of portal blood flow in the DSRS group. CONCLUSIONS: Both operations are adequate alternatives for the elective treatment of portal hypertension in low-risk patients. However, the DSRS has more advantages than the LDMCS.

[Retrospective study of 50 ileostomies at the Salvador Zubirán National Institute of Nutrition]. / Estudio retrospectivo de 50 ileostomías en el Instituto Nacional de la Nutrición Salvador Zubirán.

OBJECTIVES: To establish the diseases that motivated an ileostomy and the short and long-term morbi-mortality of the procedure. METHODS: Retrospective analysis of 50 consecutive cases of ileostomies performed from 1989-1993 at a referral center in Mexico City. RESULTS: Most ileostomies were temporary (92%); the most frequent diagnoses were multiple familial polyposis, inflammatory bowel disease, and diverse intra-abdominal inflammatory complications. Operative mortality was 22%, caused mainly by the severity of the disease that motivated the ileostomy. A reoperation was required in 14% of the cases because of stomal complications (stricture, prolapse); 6% presented peristomal dermatitis, 4% high output, and 4% associated depression. With a mean time interval of three months, 32 patients were subjected to intestinal reconnection with a morbidity of 19% but no mortality. CONCLUSIONS: Ileostomy remains a necessary procedure mainly on a temporary basis. It is convenient to prevent complications by means of adequate surgical techniques, and a better rehabilitation by a multidisciplinary team.